Every earnings call for THYROCARE — management tone, guidance, KPIs and promise tracking, quarter by quarter.
THYROCARE · 7 transcripts · Healthcare · latest Q4 FY26Thyrocare Technologies Limited has 7 earnings calls on record here, a Healthcare company, most recently Q4 FY26. Each quarter is scored on revenue, margins, guidance delivery and the questions management left unanswered — so the gap between what was promised and what was delivered is easy to read.
Consolidated Revenue ₹224 cr (+20% YoY); EBITDA (FY26) ₹262 cr (+38% YoY); EBITDA Margin 34%. Consolidated revenue grew 21% YoY in FY26 to INR829 crores and 20% YoY in Q4 FY26 to INR224 crores.
Read full transcript & analysisConsolidated Revenue ₹196 cr (+18% YoY); EPS ₹1.64 (+39% YoY). Consolidated revenue grew 18% YoY to INR 196 crores.
Read full transcript & analysisRevenue (Consolidated) ₹217 cr (+22% YoY); Normalized EBITDA Margin (Consolidated) 34.8%; Gross Margin (Standalone) 71.6%. Consolidated Revenue of ₹217 crores, up 22% YoY.
Read full transcript & analysisConsolidated Revenue ₹217 cr (+22% YoY); Standalone Gross Margin 71.6% (+1% YoY); EPS ₹9.05 (+82% YoY). Consolidated Revenue up 22% YoY to INR 217 crores.
Read full transcript & analysisConsolidated Revenue ₹193 cr (+23% YoY); PAT ₹38 cr (+62% YoY); Standalone Gross Margin 71%. Consolidated revenue grew 23% year-on-year to ₹193 crores.
Read full transcript & analysisConsolidated Revenue ₹687 cr (+20% YoY); Normalized EBITDA ₹210 cr; Normalized EBITDA Margin (FY25) 31%. Consolidated revenue for FY25 reached INR687 crores, reflecting a robust 20% year-on-year growth.
Read full transcript & analysisConsolidated Revenue ₹166 cr (+23% YoY); Consolidated Gross Margin 73%. Consolidated revenue grew 23% YoY to INR166 crores.
Read full transcript & analysis